Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies.

Haemostasis Pub Date : 1999-01-01 DOI:10.1159/000022502
G Mello, E Parretti, E Martini, F Mecacci, P La Torre, R Cioni, R Lucchetti, S Fedi, A M Gori, G Pepe, D Prisco, R Abbate
{"title":"Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies.","authors":"G Mello,&nbsp;E Parretti,&nbsp;E Martini,&nbsp;F Mecacci,&nbsp;P La Torre,&nbsp;R Cioni,&nbsp;R Lucchetti,&nbsp;S Fedi,&nbsp;A M Gori,&nbsp;G Pepe,&nbsp;D Prisco,&nbsp;R Abbate","doi":"10.1159/000022502","DOIUrl":null,"url":null,"abstract":"<p><p>Activated protein C resistance (APCR) is a common cause of familial thrombophilia and venous thrombosis. The aim of the study was to investigate the prevalence of APCR associated with factor V Leiden mutation and its relevance in comparison to other risk factors for thromboembolic disorders in women with a history of previous complicated pregnancies (history of fetal loss in the second and third trimester n = 34, preeclampsia n = 46). The frequency of APCR was significantly higher in women with a history of fetal loss and preeclampsia (23.5 and 26.1%, respectively) compared with a control group (3.8%). The prevalence of antithrombin, protein C and protein S deficiencies and the presence of antiphospholipid antibodies were also investigated: the prevalence of at least one disorder was 41.2% in the group with previous fetal loss, 37.0% in the group with previous preeclampsia and 7.5% in the control group.</p>","PeriodicalId":12910,"journal":{"name":"Haemostasis","volume":"29 4","pages":"197-203"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000022502","citationCount":"53","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haemostasis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000022502","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 53

Abstract

Activated protein C resistance (APCR) is a common cause of familial thrombophilia and venous thrombosis. The aim of the study was to investigate the prevalence of APCR associated with factor V Leiden mutation and its relevance in comparison to other risk factors for thromboembolic disorders in women with a history of previous complicated pregnancies (history of fetal loss in the second and third trimester n = 34, preeclampsia n = 46). The frequency of APCR was significantly higher in women with a history of fetal loss and preeclampsia (23.5 and 26.1%, respectively) compared with a control group (3.8%). The prevalence of antithrombin, protein C and protein S deficiencies and the presence of antiphospholipid antibodies were also investigated: the prevalence of at least one disorder was 41.2% in the group with previous fetal loss, 37.0% in the group with previous preeclampsia and 7.5% in the control group.

筛查先天性或获得性止血异常对既往复杂妊娠妇女的有用性。
活化蛋白C抵抗(APCR)是家族性血栓和静脉血栓形成的常见原因。本研究的目的是调查APCR与因子V Leiden突变相关的患病率,并将其与有复杂妊娠史(妊娠中期和晚期胎儿丢失史34例,先兆子痫46例)的妇女血栓栓塞性疾病的其他危险因素进行比较。与对照组(3.8%)相比,有胎儿丢失史和先兆子痫的妇女APCR的发生率显著高于对照组(分别为23.5%和26.1%)。还调查了抗凝血酶、蛋白C和蛋白S缺乏的患病率以及抗磷脂抗体的存在:至少有一种疾病的患病率在既往胎儿丢失组为41.2%,在既往子痫前期组为37.0%,对照组为7.5%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信